PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Pharma-Bio Serv, Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026
- Market cap
- $11.00M
- P/E (TTM)
- 48.0
- Dividend yield
- –
Share price
−$0.1326 (−21.65%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
Pharma-Bio Serv, Inc. grew revenue 3.3% to $9.48M over the twelve months to Jul 31, 2026. Free cash flow was -$421.36K.
Revenue
$9.48M
+3.3% vs. a year earlier
Operating income
-$154.94K
TTM Q3 2026
Free cash flow
-$421.36K
TTM Q3 2026
EPS, diluted
$0.01
TTM Q3 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $11.00M
- P/E ratio
- 48.0
- Price to sales
- 1.16
- Price to book
- 1.05
- Dividend yield
- –
- Free cash flow yield
- -3.83%
Fundamentals
- Revenue
- $9.48M
- Net income
- $251.53K
- EPS, diluted
- $0.01
- Free cash flow
- -$421.36K
- Book value per share
- $0.46
- Diluted shares
- 23M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$9.48M+3.3% YoY
Gross profit
$3.07M+6.1% YoY
Operating income
-$154.94K
Net income
$251.53K
EPS, diluted
$0.01
Free cash flow
-$421.36K
Reported periodTrailing twelve months